Skip to main content

Table 3 Baseline RBP4 levels predicts the incidence and persistence of MS in the 10-year prospective study

From: Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study

 

The incidence of MSa

The persistence of MSb

OR/unit (95% CI)

P

OR/unit (95% CI)

P

Model 1

1.77 (1.29–2.43)

< 0.001

2.19 (1.14–4.20)

0.018

Model 2

1.68 (1.22–2.34)

0.002

2.32 (1.18–4.45)

0.015

Model 3

1.43 (1.01–2.04)

0.049

3.85 (1.51–9.84)

0.005

Model 4

1.66 (1.19–2.30)

0.003

2.28 (1.06–4.93)

0.036

  1. OR indicates odds ratio for per 10 μg/ml (approximately 1 SD) increase in baseline RBP4 levels
  2. BMI body mass index, TG triglycerides, HDL-C high-density lipoprotein cholesterol, MS metabolic syndrome
  3. a Excludes subjects with MS at baseline
  4. b Excludes subjects without MS at baseline
  5. Model 1: adjusted for age, gender, and pubertal stage at baseline
  6. Model 2: Model 1 + additionally adjusted with physical activity, dietary score and BMI at baseline
  7. Model 3: Model 1 + additionally adjusted with waist circumference, systolic blood pressure, HDL-C, fasting blood glucose and TG levels at baseline
  8. Model 4: Model 1 + additionally adjusted with adiponectin, leptin levels and BMI at baseline
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840